IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease

被引:128
作者
Mu, W
Ouyang, X
Agarwal, A
Zhang, L
Long, DA
Cruz, PE
Roncal, CA
Glushakova, OY
Chiodo, VA
Atkinson, MA
Hauswirth, WW
Flotte, TR
Rodriguez-Iturbe, B
Johnson, RJ
机构
[1] Univ Florida, Div Nephrol, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pediat, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA
[3] Univ Florida, Inst Genet, Gainesville, FL 32610 USA
[4] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA
[5] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
[6] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA
[7] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA
[8] Univ Maracaibo, Div Nephrol, Maracaibo, Venezuela
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 12期
关键词
D O I
10.1681/ASN.2005030297
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
IL-10 is a pluripotent cytokine that plays a pivotal role in the regulation of immune and inflammatory responses. Whereas short-term administration of IL-10 has shown benefit in acute glomerulonephritis, no studies have addressed the potential benefits of IL-10 in chronic renal disease. Chronically elevated blood levels of IL-10 in rats were achieved by administration of a recombinant adeno-associated virus serotype 1 IL-10 (rAAV1-IL-10) vector. Control rats were given a similar dose of rAAV1-GFP. Four weeks after injection, IL-10 levels in serum were measured by ELISA, and chronic renal disease was induced by a 5/6 nephrectomy (n = 6 in each group). Eight weeks later, rats were killed and renal tissue was obtained for RNA, protein, and immunohistochemical analysis. Serum levels of IL-10 were 12-fold greater in the rAAV1-IL-.10 group by 4 wk after rAAV1-IL-10 administration (345 +/- 169 versus 28 15 pg/ml; P = 0.001), and levels were maintained throughout the experiment. rAAV1-IL-10 treatment resulted in less proteinuria (P < 0.05), lower serum creatinine (P < 0.05), and higher creatinine clearances (P < 0.01) compared with rAAV1-GFP-treated rats. Renal interstitial infiltration was significantly attenuated by rAAV1-IL-10 administration as assessed by numbers of CD4(+), CD8(+), monocyte-macrophages (ED-1(+)) and dendritic (OX-62(+)) cells (P < 0.05), and this correlated with reductions in the renal expression of monocyte (renal monocyte chemoattractant protein-1 mRNA and protein) and T cell (RANTES mRNA) chemokines. rAAV1-IL-10 administration decreased mRNA levels of IFN-gamma and IL-2 in the kidney. The reduction in inflammatory cells was associated with a significant reduction in glomerulosclerosis and interstitial fibrosis. It is concluded that IL-10 blocks inflammation and improves renal function in this model of chronic renal disease. The feasibility of long-term overexpression of a gene using the AAV serotype 1 vector system in a model of renal disease is also demonstrated.
引用
收藏
页码:3651 / 3660
页数:10
相关论文
共 54 条
[31]   IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo [J].
Mazighi, M ;
Pellé, A ;
Gonzalez, W ;
Mtairag, EM ;
Philippe, M ;
Hénin, D ;
Michel, JB ;
Feldman, LJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (02) :H866-H871
[32]   Interleukin-10 and the interleukin-10 receptor [J].
Moore, KW ;
Malefyt, RD ;
Coffman, RL ;
O'Garra, A .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :683-765
[33]   B7 AND INTERLEUKIN-12 COOPERATE FOR PROLIFERATION AND INTERFERON-GAMMA PRODUCTION BY MOUSE T-HELPER CLONES THAT ARE UNRESPONSIVE TO B7 COSTIMULATION [J].
MURPHY, EE ;
TERRES, G ;
MACATONIA, SE ;
HSIEH, CS ;
MATTSON, J ;
LANIER, L ;
WYSOCKA, M ;
TRINCHIERI, G ;
MURPHY, K ;
OGARRA, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :223-231
[34]   IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways [J].
O'Farrell, AM ;
Liu, Y ;
Moore, KW ;
Mui, ALF .
EMBO JOURNAL, 1998, 17 (04) :1006-1018
[35]   Expression of monocyte chemoattractant protein-1 in proximal tubular epithelial cells in a rat model of progressive kidney failure [J].
Ota, T ;
Tamura, M ;
Osajima, A ;
Doi, Y ;
Kudo, H ;
Anai, H ;
Miyazaki, M ;
Nishino, T ;
Nakashima, Y .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002, 140 (01) :43-51
[36]   Adherence modifies the regulation of gene expression induced by interleukin-10 [J].
Petit-Bertron, AF ;
Pedron, T ;
Gross, U ;
Coppée, JY ;
Sansonetti, PJ ;
Cavaillon, JM ;
Adib-Conquy, M .
CYTOKINE, 2005, 29 (01) :1-12
[37]  
RALPH P, 1992, J IMMUNOL, V148, P808
[38]   Role of immunocompetent cells in nonimmune renal diseases [J].
Rodríguez-Iturbe, B ;
Pons, H ;
Herrera-Acosta, J ;
Johnson, RJ .
KIDNEY INTERNATIONAL, 2001, 59 (05) :1626-1640
[39]   Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats [J].
Romero, F ;
Rodríguez-Iturbe, B ;
Parra, G ;
González, L ;
Herrera-Acosta, J ;
Tapia, E .
KIDNEY INTERNATIONAL, 1999, 55 (03) :945-955
[40]   Focal glomerulosclerosis in the remnant kidney model - An inflammatory disease mediated by cytokines [J].
Schiller, B ;
Moran, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (03) :430-437